Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

ResMed Promotes Mick Farrell to Replace Father as CEO

ResMed Inc., a maker of machines to regulate breathing for people with sleep disorders, promoted Mick Farrell to replace his father as chief executive officer.

Farrell, 40, has served as president of the Americas since 2011, overseeing a division where sales rose more than 30 percent in the past seven quarters, the Poway, California-based company said in a statement today. His father, Peter Farrell, 70, will remain executive chairman through the end of the year, then serve as non-executive chairman.

Rob Douglas, the chief operating officer, will assume the role of president, the company said. ResMed generated more than half of its $1.4 billion in sales last fiscal year in the U.S.

“It was easily determined that members of the very talented and experienced team that have driven much of the company’s great success over the past decade would be the best suited to lead the company to its next stage of growth and development,” said Gary Pace, ResMed’s lead director and chairman of the board’s succession committee.

Before joining ResMed in 2001, Mick Farrell worked for Genzyme Corp., Dow Chemical Co., Arthur D. Little and BHP Billiton Ltd. He has a bachelor’s of engineering degree from the University of New South Wales and a master’s of science from the Massachusetts Institute of Technology.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.